medRxiv PreprintsInternational12 October 2026
Label-free, low-cost AI ranking for systematic review screening
This is an official announcement record
Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.
Title and abstract screening is among the most labor-intensive steps of systematic reviews. Jev, a low-cost AI decision model, scores records against eligibility criteria without screening labels. We scored 169,982 records from 128 reviews and, after tuning on development reviews, evaluated 23 held-out reviews once and 31 Cochrane reviews post hoc. Jev outranked the best free ranker in all 23 held-out reviews (mean AUC 0.966 vs 0.831) and came within 0.011 AUC of Claude Opus 5.5 on 1999 records at about 1/700 of its list-price cost (US$0.02/1000 records). Combined with active learning, it rais
Read the official announcement
Opens www.medrxiv.org
More from medRxiv Preprints
- Upper cervical spinal cord morphometric charts: from population references to individualized clinical assessment12 October 2026
- Computational modelling of decision-making in suicide attempters12 October 2026
- Efficacy of Repeated-Dose Albendazole/ Mebendazole Regimens for Soil-Transmitted Helminth Infections in Paediatric Population: A Systematic Review and Meta-Analysis12 October 2026
- Dynamics of a slow-burn epidemic: the genomic epidemiology of poultry-associated Campylobacter jejuni ST474 in New Zealand12 October 2026
- EpiAlert: A Transparent CUSUM-EWMA Framework for Early Warning of Unusual Influenza-Like Illness Surveillance Activity12 October 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program — especially if you are pregnant, nursing, taking medication, or managing a health condition.